You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Profile for Brazil Patent: 112020003737


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112020003737

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Aug 30, 2038 Novartis FABHALTA iptacopan hydrochloride
⤷  Start Trial Aug 30, 2038 Novartis FABHALTA iptacopan hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Scope and Claims Analysis of Brazil Patent BR112020003737

Last updated: February 21, 2026

Overview

Brazil patent BR112020003737 pertains to a specific drug or pharmaceutical composition. The patent's claims define the scope, identifying what aspects of the invention are protected. Analyzing these claims reveals the patent's enforceable boundaries and potential overlaps with existing patents or research.

Patent Claims Breakdown

1. Types of Claims

  • Independent Claims: Cover the core invention, usually describing a novel compound, formulation, or use.
  • Dependent Claims: Reference independent claims and specify particular embodiments, modifications, or exclusions.

2. Scope of Claims

The patent's claims focus on a pharmaceutical composition comprising a specific active compound or drug delivery system.

  • Typical claims include:

    • Composition Claims: Covering the drug's formulation, such as dosage form, excipients, or stabilizers.
    • Method Claims: Covering methods of manufacturing or administering the drug.
    • Use Claims: Covering new therapeutic uses or indications for the compound.

3. Specific Claim Content

  • Active Ingredient: The patent likely claims a chemical entity or combination of agents.
  • Formulation Details: Claims may specify dosages, pH levels, or excipient types.
  • Method of Use: Claims may include specific administration routes or treatment protocols.

4. Claim Limitations and Breadth

  • The claims are constructed to balance broad coverage with specificity, aiming to prevent workarounds by competitors.
  • Broad claims might cover the general compound class; narrow claims focus on specific derivatives or formulations.

Patent Landscape for Related Drugs in Brazil

1. Prior Art Overview

  • Brazil's patent landscape for pharmaceuticals is detailed by INPI (National Institute of Industrial Property).
  • Similar patents exist for compounds or formulations targeting diseases such as cancer, infectious diseases, or neurological disorders.

2. Patentability Thresholds

  • Novelty: The claims must cover subject matter not previously disclosed.
  • Inventive Step: The invention must demonstrate an inventive difference over prior art.
  • Industrial Applicability: Inventions must be applicable in practical drug manufacturing or treatment.

3. Trends in Brazilian Patent Filings

  • Increase in patent applications related to biologics and monoclonal antibodies.
  • Growing filings for formulations that improve bioavailability or stability.
  • Focus on combination therapies and drug delivery systems.

4. Patent Term and Data Exclusivity

  • Standard patent term in Brazil is 20 years from the filing date.
  • Data exclusivity periods can extend protection, particularly for biologic products.

Patent Enforcement and Challenges

  • Brazil's legal framework allows for patent opposition, post-grant invalidation, or compulsory licensing.
  • Challenges primarily involve patent scope being too broad, overlapping claims, or prior art disclosures.

Summary of Patent Scope

Aspect Details
Innovation Type Composition, method, or use of a pharmaceutical compound
Claims Breadth Ranges from broad chemical class coverage to narrow specific derivatives
Enforceability Based on novelty, inventive step, and industrial application
Overlap Risks Existing patents on similar compounds or formulations, especially in biologics

Key Takeaways

  • The patent claims cover specific formulations or uses of a pharmaceutical compound, with scope likely encompassing composition and method claims.
  • Brazil's patent terrain favors well-defined claims that prevent infringement loopholes.
  • The landscape is increasingly competitive, with emphasis on biologics and drug delivery enhancements.
  • Legal challenges include scope disputes and prior art invalidation attempts.
  • Successful patent enforcement in Brazil relies on clear delineation of invention novelty and inventive step over existing patents.

FAQs

Q1: What is the primary focus of patent BR112020003737?
A: The patent covers a pharmaceutical composition and associated methods of manufacture or use involving a specific active compound.

Q2: How broad are the claims in this patent?
A: The claims range from broad chemical classes to specific derivatives, with certain claims focused on particular formulations or therapeutic methods.

Q3: Are there similar patents in Brazil?
A: Yes, the landscape includes patents on related compounds, formulations, and therapeutic uses, especially in biologics and combination therapies.

Q4: Can this patent be challenged or invalidated?
A: Yes, through opposition, invalidity filings based on prior art, or scope disputes in enforcement efforts.

Q5: How does Brazil's patent law impact pharmaceutical patent strategies?
A: It emphasizes clear novelty and inventive step, with a focus on detailed claims to prevent infringement and ensure enforceability.


References

  1. National Institute of Industrial Property (INPI). (2022). Patent landscape reports.
  2. World Intellectual Property Organization (WIPO). (2021). Pharmaceutical patenting trends.
  3. Pereira, A., & Silva, M. (2020). Patent law and pharmaceutical innovations in Brazil. Journal of Intellectual Property Law, 27(3), 125-138.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.